What is the role of immune cell therapy in the treatment of lung cancer?

Beijing Wanbo Hospital of Traditional Chinese Medicine, they can do cell biology**, now they are doing biological cell donation projects, I am also a cancer patient, the effect is OK twice, I really don't want to trouble my children anymore, they asked to come to this hospital, in fact, now I am happy to live every day, looking at my children, grandchildren, happy is very content, I wish you an early **. **One-to-one. **One-to-one.

——— try the three-in-one anti-cancer drug Wuzhi, which integrates inhibiting cancer cells + improving immunity + supplementing the nutrition of cancer patients.

Security is not ***.

At present, the first and second lines of lung cancer are generally chemoradiotherapy, targeted drugs, etc. Biological immunity** is not very effective and stable at present, and it is a relatively new method, so it is not recommended as a first-line method**.

The first floor is a layman, this ** is generally 30,000 a course of treatment, how much does it cost to do 9 times? Whether it is early cellular immunity or current API-specific biological immunity**, it is generally 1 course of treatment. It is important to know that for a disease like lung cancer, it is difficult to have a good effect with surgery or chemotherapy and radiotherapy, so it is recommended that biology cooperate with tradition to achieve better results.

Don't listen to the doctor's foolishness, it just makes you burn money. I did it nine times. Doctors outside of oncology will tell you very clearly that it's useless.

It plays a very important role in inhibiting the spread of cancer cells through immunity, which can further control the disease, and then you can go to surgery to clean up the diseased tissue.

Immunity plays a supportive role in the process of lung cancer, and the antiviral effect is achieved by enhancing the body's immunity.

Lung cancer immunity** is a very big progress in lung cancer**, which can be used for new adjuvant lung cancer in the early stage**, as well as maintenance ** after concurrent chemoradiotherapy in locally advanced stage**, and can also be used for advanced immunity**.

Immunity plays a very large role in lung cancer. This is an indispensable step in lung cancer.

It will play a vital role, because in the case of lung cancer, if this immunization method is adopted, it is possible that it will not continue to get this level, and the recovery process is also very fast.

Dr. Li Yucong of the Department of Clinical Oncology pointed out in an interview that the 1-year survival rate of patients with stage 4 non-small cell lung cancer is only 14%, and the 5-year survival rate is 0%, the main reason is that most of the stage 4 tumors have spread to organs other than the lungs, such as bones, etc., and the options and results are limited.

An international study called impower150 found that the combination of immune** (atezolib), targeted drugs (bevacizumab) and chemotherapy** could prolong the progression-free survival and overall survival of patients with non-genetic mutant stage 4 non-small cell lung cancer (NSCLC) by nearly two months to a median of nearly two months and a median of one month to a month in the latter compared with targeted drugs and chemotherapy alone.

Genetic mutations are more effective.

Li Yucong continued to point out that the study also found that even if the above patients were accompanied by liver metastases, the overall median survival time was also improved, which could be extended by 4 months. For patients with EGFR or ALK gene mutations, although they have received relevant targets** but failed, but when immunization** is added to the second line**, their survival is significantly prolonged, indicating that this combination** is effective for patients.

The effect of lung cancer biological immunity** should be measured for the content of PDL1. The purpose of tumor immunity** is to stimulate and mobilize the body's immune system, enhance the tumor microenvironment, anti-tumor immunity, and thus control and kill cells. There are now several categories of immunity** against tumors, especially lung cancer

For PDL1 inhibitors and immunoassay inhibitors, the currently domestically marketed durvalumab and atezolizumab for PD1 are pembrolizumab, nivolumab, camrelizumab, sindilil and terprelil. The effect of immunity is mainly to detect the content of PDL1, such as the content of PDL1 TPS is greater than 50%, and the effect of immune checkpoint inhibitors alone is better, such as PDL1 positive, that is, TPS positive in 1 to 49%, the effect of this monotherapy immune checkpoint inhibitor is worse, but if he combines chemotherapy, the effective rate of ORR will be greatly improved, for PDL1 is negative, referring to less than 1% of patients, it is recommended that chemotherapy combined with immunoassay inhibitors, to perform anti-tumor**.

It's better to go to see traditional Chinese medicine, because modern Western medicine can only rely on radiotherapy and chemotherapy, so that the patient can't withstand the poison and declares it a failure, thus delaying the opportunity.

How to say it, it's already in the advanced stage, ** or something is to comfort the family, do a good job of dying comfort, chemotherapy is not effective.

Small, the patient is not guilty, the effect is good, but the cost is high! It is not bad to reduce the lesion after appropriate radiotherapy first, and then carry out biological immunity**!

It can prolong the life cycle of the patient.

**Just an indicator in the process of buying a product or service, if you simply compare**, in fact, the consideration is not so thoughtful. **, quality, service, reputation, whether it is suitable for their own situation, etc. need to be considered together.

Small cell lung cancer accounts for about 15%-20% of bronchial lung cancers, and when small cell lung cancer is diagnosed, about 30% of patients with limited stage tumors are in the advanced stage, and the rest are in the extensive stage, which is when the tumor spreads beyond the supraclavicular region. Compared with other types of lung cancer, small cell lung cancer has better response to chemotherapy and radiotherapy.

Lung cancer is a common malignant tumor of the respiratory system, the disease can have no symptoms in the early stage, with the progress of the tumor can appear cough, sputum and blood in the sputum, can also be accompanied by chest tightness, chest pain and dyspnea and other symptoms, small cell lung cancer generally takes chemotherapy-based comprehensive **, the specific cost can not be determined, you also need to consult the local hospital.

For lung cancer, surgery, chemotherapy, radiotherapy, intervention, molecular targeting, biological immune cells, genes and other multidisciplinary aspects should be used. Immunization** once, 4 times.

For lung cancer, TCM syndrome differentiation and treatment should be combined with surgery, chemotherapy, radiotherapy, intervention, molecular targeting, biology, genetics and other multidisciplinary participation.

Lung Cancer Immunization**The specific cost also has a certain relationship with the hospital you choose. Lung cancer now also has a way of immunization**, which is more expensive and carries out according to the actual situation**.

1. What should I do if I have lung cancer?

2. How to prevent lung cancer?